Literature DB >> 6171497

Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, V. Attachments of carbohydrates in the human urinary trypsin inhibitor isolated by affinity chromatography.

K Hochstrasser, O L Schönberger, I Rossmanith, E Wachter.   

Abstract

The inhibitory active part of the inter-alpha-trypsin inhibitor with a known amino acid sequence is present as an acid-resistant inhibitor in human serum, in urine, in bronchial and in nasal mucus. The inhibitor molecule has a 50% carbohydrate content. Carbohydrate side chains are attached in two positions. One chain is linked to the polypeptide O-glycosidically via the serine residue in position 10 in the N-terminal extension peptide. The second side chain is attached N-glycosidically via the asparagine residue in position 24, located in the inactive "inhibitory" Kunitz-type domain of the inhibitor. The composition of the carbohydrate side chains were determined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171497     DOI: 10.1515/bchm2.1981.362.2.1357

Source DB:  PubMed          Journal:  Hoppe Seylers Z Physiol Chem        ISSN: 0018-4888


  10 in total

1.  Amino acid distributions around O-linked glycosylation sites.

Authors:  I B Wilson; Y Gavel; G von Heijne
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

2.  Immunological evaluation of urinary trypsin inhibitors in blood and urine: role of N- & O-linked glycoproteins.

Authors:  Michael J Pugia; Saeed A Jortani; Manju Basu; Ronald Sommer; Hai-Hang Kuo; Solomon Murphy; Doug Williamson; James Vranish; Patrick J Boyle; Danny Budzinski; Roland Valdes; Subhash C Basu
Journal:  Glycoconj J       Date:  2007-01       Impact factor: 2.916

3.  pH induces thermal unfolding of UTI: an implication of reversible and irreversible mechanism based on the analysis of thermal stability, thermodynamic, conformational characterization.

Authors:  Handong Fan; Jing Liu; Wendan Ren; Zhongliang Zheng; Yuying Zhang; Xi Yang; Huaping Li; Xiaoyan Wang; Guolin Zou
Journal:  J Fluoresc       Date:  2007-11-09       Impact factor: 2.217

Review 4.  A physiological function of serum proteoglycan bikunin: the chondroitin sulfate moiety plays a central role.

Authors:  Lisheng Zhuo; Antonietta Salustri; Koji Kimata
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

5.  The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-alpha-trypsin inhibitor also encodes alpha-1-microglobulin (protein HC).

Authors:  J F Kaumeyer; J O Polazzi; M P Kotick
Journal:  Nucleic Acids Res       Date:  1986-10-24       Impact factor: 16.971

6.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

7.  Isolation and characterization of cDNAs encoding the heavy chain of human inter-alpha-trypsin inhibitor (I alpha TI): unambiguous evidence for multipolypeptide chain structure of I alpha TI.

Authors:  J P Salier; M Diarra-Mehrpour; R Sesboue; J Bourguignon; R Benarous; I Ohkubo; S Kurachi; K Kurachi; J P Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).

Authors:  M W Swaim; S V Pizzo
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

9.  Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase.

Authors:  J E Hansen; O Lund; J Engelbrecht; H Bohr; J O Nielsen; J E Hansen
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

10.  Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion.

Authors:  H Kobayashi; H Shinohara; H Ohi; M Sugimura; T Terao; M Fujie
Journal:  Clin Exp Metastasis       Date:  1994-03       Impact factor: 5.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.